Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA).On Dec. 20, ...

The FDA suggests that prescribed users also reduce their calorie intake and increase their exercise The weight loss drug ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...

The FDA first approved Zepbound to treat obesity in ... Medicare does not cover weight-loss drugs specifically for obesity, although the medications can be covered for conditions exacerbated ...

The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...

The FDA has announced that popular weight loss medication tirzepatide is no longer ... in this case tirzepatide — but are not FDA-approved, although the manufacturers are held to other ...

For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...